# Vaxcyte, Inc.: Form 8-K, filed Feb 27, 2023

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2023-02-27
- Accepted by EDGAR: Feb 27, 2023, 16:04 ET
- Period: 2023-02-27
- Accession: 0000950170-23-004639
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000095017023004639/pcvx-20230227.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000095017023004639/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000095017023004639/pcvx-20230227.htm

Filed Feb 27, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-004639. Last ingested by Listed: Nov 14, 2026, 19:29 ET. No prices; not investment advice.
